CCCR News and Updates
31 - 35 of 35
Nanoparticles May Exploit Tumor Weaknesses to Selectively Attack Cancers
Published on
Delving into the world of the extremely small, CHOP researchers are exploring how nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma.
Benefits Persist in T Cell Therapy for Children With Relapsed Leukemia
Published on
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study.
New Chief of Oncology Named by The Children’s Hospital of Philadelphia
Published on
CHOP announces the selection of Stephen P. Hunger, MD, a nationally prominent specialist in children’s cancer, as its new chief of the Division of Oncology and the director of the Center for Childhood Cancer Research.
Classification of Gene Mutations in a Children’s Cancer May Point to Improved Treatments
Published on
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.
Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied
Published on
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.